What is the best strategy to target LDL-C levels and improve cardiovascular outcomes?
Read More »Liraglutide Use in Heart Failure Patients
Cardioprotective effects of the drug are focus of research.
Read More »Uncovering the Cardiovascular Effects of Pioglitazone
Is pioglitazone a viable option for patients with insulin resistance and recent stroke or myocardial infarction?
Read More »Leisure Exercise Reduces Heart Disease by 25% for Younger Women
We have studies that show exercise for older women is very beneficial; new study shows benefits for the young.
Read More »GLP-1 Receptor Agonist vs Insulin: Mortality Rate and Cardiovascular Risk
Does insulin cause more deaths and cardiovascular outcomes than GLP-1 agonist receptors?
Read More »Lowering LDL with the New PCSK9 Inhibitors
In part 3 of this exclusive interview, Dr. Eckel discusses the new PCSK9 Inhibitors and their LDL-lowering effects, and why they are beneficial for statin-intolerant patients.
Read More »Effect of Lipid Lowering Drugs on Type 2 Diabetes
ETC-1002 may offer new therapeutic option that does not decrease glycemic control.
Read More »Diabetes, Kidney Problems and Cardiovascular Risk in Minority Patients
Prevalence of early CKD higher among Hispanics and African Americans.
Read More »Exercising and Cardiovascular Risk
Is moderate exercising helping or hurting cardiovascular outcomes?
Read More »High Cholesterol: a Silent Killer that Needs Immediate Attention
Is high cholesterol associated with risk of type 2, cardiovascular diseases and high mortality rates?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.